חוב לטווח קצר להון עצמי Impact BioMedical, Inc. (IBO)

Impact BioMedical Inc (IBO) is developing diversified biomedical projects. This price chart on the GURU.Markets platform illustrates investor distrust toward opaque management and a complex ownership structure, where the metric stands at 0.00. The business relies on the synergy of treatments for diabetes and viruses. Stable revenues guarantee the defensive qualities of the assets, which remain virtually independent of global economic shocks.

To identify the sector's fundamental leaders, the analyst evaluates the ratio of liabilities maturing within one year to equity, which determines the business's ability to service urgent debts without compromising solvency. Amid geopolitical risks and raw material supply disruptions for Impact BioMedical Inc (IBO), this calculation is critical, as the current level of short-term capital load reflects the company's financial margin of safety in the event of restricted sales markets.